tert-butyl(dimethyl)[(2E)-2-penten-4-ynyloxy]silane → 4-((3E)-5-{[tert-butyl(dimethyl)silyl]oxy}-3-penten-1-ynyl)-6-phenoxypyrimidin-5-amine
Reaction equation
I[C:2]1[C:7]([NH2:8])=[C:6]([O:9][C:10]2[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=2)[N:5]=[CH:4][N:3]=1.[C:16]([Si:20]([CH3:28])([CH3:27])[O:21][CH2:22]/[CH:23]=[CH:24]/[C:25]#[CH:26])([CH3:19])([CH3:18])[CH3:17]>C(#N)C.C(N(CC)CC)C.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[Cu]I>[Si:20]([O:21][CH2:22]/[CH:23]=[CH:24]/[C:25]#[C:26][C:2]1[C:7]([NH2:8])=[C:6]([O:9][C:10]2[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=2)[N:5]=[CH:4][N:3]=1)([C:16]([CH3:17])([CH3:18])[CH3:19])([CH3:28])[CH3:27]Participants
7
Reactant 2
Product 1
Reagents, catalysts & solvents 4
Procedure
4-Iodo-6-phenoxypyrimidin-5-amine (1.0 g) was dissolved in a mixed solvent of acetonitrile (53 mL)/triethylamine (39 mL), and tert-butyl(dimethyl)[(2E)-2-penten-4-ynyloxy]silane (753 mg), trans-dichlorobis(triphenylphosphine)palladium(II) (112 mg) and copper(I) iodide (36.5 mg) were sequentially added. The title compound (1.07 g) was obtained as crystals by the reaction in the same manner as in Example 9 (iv).
Workup
- additionwere sequentially added
Sources & evidence
- ORD record
- ord-ccbcaae9a5f940c3a8350c0dd2d6f435
- Source dataset
- uspto-grants-2009_03
- Patent number
- US07507740B2
Reaction notes
Loading…